BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Generex Biotechnology Corporation 

33 Harbour Square
Suite 202
Toronto  Ontario  M5J 2G2  Canada
Phone: 416-364-2551 Fax: 416-364-9363


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Drug Delivery





 Company News
Generex Biotechnology Corporation (GNBT) Announces Publication Of Ebola Vaccine White Paper By Antigen Express, Inc. (GNBT) 10/21/2014 9:30:53 AM
Generex Biotechnology Corporation (GNBT) Clarifies Utility Of Antigen Express Technology For Potential Ebola Vaccine 10/7/2014 9:43:37 AM
Generex Biotechnology Corporation (GNBT) Collaborates With University Health Network For Buccal Insulin Project 9/22/2014 8:12:49 AM
Generex Biotechnology Corporation (GNBT) / Antigen Express, Inc. (GNBT) To Participate In BioPharm America™ 2014 9/3/2014 9:09:38 AM
Generex Biotechnology Corporation (GNBT) Announces Publication Of AE37 Prostate Cancer Vaccine Study 8/6/2014 8:45:03 AM
Generex Biotechnology Corporation (GNBT) Announces Interview Of Dr. Eric Von Hofe, President Of Antigen Express, Inc. (GNBT), Following Recent Keynote Presentation 6/17/2014 10:27:43 AM
Generex Biotechnology Corporation (GNBT)/Antigen Express, Inc. (GNBT) Announce Interview Of MD Anderson Cancer Center's Dr. Elizabeth Mittendorf, Principal Investigator On Company's AE37 Phase IIb Breast Cancer Efficacy Trial 6/13/2014 12:45:03 PM
Generex Biotechnology Corporation (GNBT)/Antigen Express, Inc. (GNBT) Announce Interview Of MD Anderson Cancer Center's Dr. Elizabeth Mittendorf, Principal Investigator On Company's AE37 Phase IIb Breast Cancer Efficacy Trial 6/12/2014 8:21:57 AM
Generex Biotechnology Corporation (GNBT) / Antigen Express, Inc. (GNBT) To Participate In 2014 Biotechnology Industry Organization (BIO) International Convention 6/10/2014 7:49:21 AM
Generex Biotechnology Corporation (GNBT) Announces Presentation Of Primary Efficacy Data & Immunological Response From The Phase II Study Of AE37 Cancer Vaccine At American Society of Clinical Oncology 5/20/2014 8:32:15 AM
12345678910...